NHS (Neuberger High Yield Strategies Fund Inc.) Stock Analysis - News
Neuberger High Yield Strategies Fund Inc. (NHS) is a publicly traded Financial Services sector company. As of May 21, 2026, NHS trades at $6.25 with a market cap of $197.31M and a P/E ratio of 0.00. NHS moved +0.56% today. Year to date, NHS is -15.88%; over the trailing twelve months it is -16.56%. Its 52-week range spans $6.13 to $8.67. Rallies surfaces NHS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
What changed in NHS news today?
Neuberger Fund Raises $68 Million in Oversubscribed $6.50 Rights Offering: Neuberger High Yield Strategies Fund set its final subscription price at $6.50 per share, representing 92.5% of NAV, and issued 10,463,948 new shares in an oversubscribed rights offering. The Fund expects gross proceeds of approximately $68.0 million and will issue shares on April 21, 2026.
Kocinski Chris bought 6.00K (~$44.40K) on Jul 17, 2025.
Kocinski Chris bought 15.00K (~$111.60K) on May 29, 2025.
Lind Joseph bought 5.00K (~$45.71K) on Jun 7, 2022.
NHS Analyst Consensus
NHS analyst coverage data. Average price target: $0.00.
Common questions about NHS
What changed in NHS news today?
Neuberger Fund Raises $68 Million in Oversubscribed $6.50 Rights Offering: Neuberger High Yield Strategies Fund set its final subscription price at $6.50 per share, representing 92.5% of NAV, and issued 10,463,948 new shares in an oversubscribed rights offering. The Fund expects gross proceeds of approximately $68.0 million and will issue shares on April 21, 2026.
Does Rallies summarize NHS news?
Yes. Rallies summarizes NHS news with ticker-specific context, catalysts, source links, and AI-generated market summaries when news is available.
Is NHS research on Rallies investment advice?
No. Rallies provides research, data, and educational context for NHS. It does not provide personalized investment advice.
